Infleqtion (NYSE:INFQ) Director David Singer Sells 1,797,637 Shares of Stock

Infleqtion (NYSE:INFQ) Director David Singer sold 1,797,637 shares of the company’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $16.10, for a total value of $28,941,955.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Infleqtion Price Performance

Shares of NYSE:INFQ opened at $16.15 on Friday. The firm has a market capitalization of $3.52 billion and a price-to-earnings ratio of -179.39. Infleqtion has a 52-week low of $8.52 and a 52-week high of $27.50.

Infleqtion (NYSE:INFQ) last issued its earnings results on Tuesday, March 31st. The quantum tech company reported ($0.83) earnings per share (EPS) for the quarter.

Key Stories Impacting Infleqtion

Here are the key news stories impacting Infleqtion this week:

• Positive Sentiment: Infleqtion announced a major expansion of its UK quantum operations with a new Oxford Innovation Centre and manufacturing hub, which supports its long-term growth and capacity story. Article Title
• Positive Sentiment: Market commentary also highlighted Infleqtion’s plan to expand production capacity by threefold, which investors are reading as a signal of expected demand growth. Article Title
• Positive Sentiment: Reports that the U.S. government may invest up to $100 million in Infleqtion and other quantum names have boosted sentiment around the sector and validated the company’s strategic importance. Article Title
• Neutral Sentiment: Wall Street remains generally constructive, with several Buy ratings and an average price target near $21, though the stock remains volatile. Article Title
• Negative Sentiment: Large insider sales are a key overhang, including Director David B. Singer’s multimillion-share disposals and CEO Matthew John Kinsella’s repeated sales, which may be pressuring the stock. Article Title
• Negative Sentiment: More recent filings show CRO Paul Lipman sold 100,000 shares, adding to concerns that insiders are trimming exposure after the recent rally. Article Title

Analyst Upgrades and Downgrades

INFQ has been the subject of several recent analyst reports. UBS Group initiated coverage on Infleqtion in a research note on Wednesday, April 29th. They set a “buy” rating for the company. BTIG Research initiated coverage on Infleqtion in a research note on Friday, April 10th. They set a “buy” rating and a $22.00 target price for the company. Wall Street Zen raised Infleqtion from a “sell” rating to a “hold” rating in a research note on Saturday. Citigroup initiated coverage on Infleqtion in a research note on Tuesday, April 14th. They set a “buy” rating and a $20.00 target price for the company. Finally, Weiss Ratings initiated coverage on Infleqtion in a research note on Wednesday. They set a “sell (d)” rating for the company. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

About Infleqtion

We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.